Skip to main content
. Author manuscript; available in PMC: 2010 Feb 1.
Published in final edited form as: Neuropsychopharmacology. 2009 Apr 22;34(9):2143–2155. doi: 10.1038/npp.2009.40

Table 3.

Effects of Sp-cAMPS on performance on the variable-short inter-trial interval version of the 5CSRTT

Vehicle Sp-cAMPS (2.1 nmol/0.5 μl/side)

0.5-s 1.5-s 3.0-s 4.5-s 0.5-s 1.5-s 3.0-s 4.5-s

% Accuracy
48.4 ± 8.0 67.1 ± 3.9* 67.5 ± 5.8* 72.9 ± 4.9* 53.6 ± 6.3 73.4 ± 3.1* 80.0 ± 3.4* 74.1 ± 3.4*
% Omissions 60.0 ± 6.2 39.1 ± 6.5* 20.3 ± 5.3* 13.6 ± 4.8* 55.2 ± 4.4 38.2 ± 4.6* 25.2 ± 5.8* 23.0 ± 6.3*

Note: There was an ITI duration-dependent effect on both accuracy and omissions whereby accuracy was impaired at the shortest ITI (0.5-s) and omissions were increased at the shortest ITI compared to the longer ITIs, but Sp-cAMPS did not further affect performance at any ITI.

*

P<0.05, within-subjects comparison.